Cardiovascular Involvement in Kawasaki Disease Is Much More Than Mere Coronary Arteritis

Rakesh Kumar Pilania1, Ankur Kumar Jindal1, Dharmagat Bhattarai1

  • 1Allergy Immunology Unit, Department of Paediatrics, Advances Paediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Frontiers in Pediatrics
|October 19, 2020
PubMed

Insights

Kawasaki disease (KD) is a common cause of childhood heart disease, often involving the heart muscle and other structures beyond coronary arteries. Recognizing these non-coronary complications is crucial for comprehensive patient care.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Cardiovascular Complications

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • Coronary artery abnormalities are the most recognized serious complication of KD.
  • Non-coronary cardiac manifestations of KD are frequently overlooked.

Purpose of the Study:

  • To highlight the spectrum of non-coronary cardiac complications in Kawasaki disease.
  • To emphasize the importance of recognizing myocarditis, pericardial, and valvular involvement.
  • To discuss the emerging recognition of KD shock syndrome and endothelial dysfunction.

Main Methods:

  • Review of existing literature on Kawasaki disease complications.
  • Analysis of reported cases of non-coronary cardiac involvement.
  • Clinical differentiation of KD shock syndrome from toxic shock syndrome.

Main Results:

  • Myocarditis is an integral and potentially common component of KD, possibly more frequent than coronary artery issues.
  • Pericardial effusion and valvular abnormalities are observed in KD patients.
  • KD shock syndrome is increasingly recognized, posing diagnostic challenges.
  • Endothelial dysfunction is noted in acute and follow-up stages, representing a potential cardiovascular risk factor.

Conclusions:

  • Non-coronary cardiac complications are significant in Kawasaki disease and warrant greater clinical attention.
  • Early identification and management of these complications are essential for improving long-term outcomes.
  • Endothelial dysfunction represents a modifiable risk factor for cardiovascular health in KD survivors.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
259
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
283
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
218
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
244
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
147
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
715